Your browser doesn't support javascript.
loading
Effect of intradialytic resistance training on pulse wave velocity and associated cardiovascular disease biomarkers in end stage renal disease.
Chan, Danwin; Green, Simon; Fiatarone Singh, Maria A; Barnard, Robert; Bonder, Claudine S; Cheema, Birinder S.
Afiliação
  • Chan D; School of Science and Health, Western Sydney University, Sydney, New South Wales, Australia.
  • Green S; School of Science and Health, Western Sydney University, Sydney, New South Wales, Australia.
  • Fiatarone Singh MA; Exercise, Health & Performance Faculty Research Group, Faculty of Health Sciences and Sydney Medical School, University of Sydney, Sydney, Australia.
  • Barnard R; Hebrew SeniorLife and Jean Mayer USDA Human Nutrition Center on Aging at Tufts University, Boston, Massachusetts, USA.
  • Bonder CS; Centre for Physical Activity in Ageing, Central Adelaide Local Health Network, Adelaide, Australia.
  • Cheema BS; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia.
Nephrology (Carlton) ; 23(11): 1055-1062, 2018 Nov.
Article em En | MEDLINE | ID: mdl-29265637
ABSTRACT

AIMS:

Cardiovascular disease (CVD) is the leading cause of mortality in patients with end-stage renal disease (ESRD) receiving maintenance haemodialysis treatment. This study investigated the effect of a 12-week intradialytic progressive resistance training (PRT) intervention on pulse wave velocity (PWV) and associated haemodynamic, anthropometric, and hematologic outcomes in patients with ESRD.

METHODS:

Twenty-two patients with ESRD (59% men, 71.3 ± 11.0 years) were recruited. Supervised PRT (three sets of 11 exercises) was prescribed three times per week during routine dialysis. The primary outcome was brachial-ankle PWV via applanation tonometry. Secondary outcomes included augmentation index, brachial and aortic blood pressures, endothelial progenitor cells, C-reactive protein, blood lipids and anthropometrics.

RESULTS:

The intradialytic PRT regimen resulted in no significant change in PWV between control and intervention periods [mean difference = 0 (95% CI = -0.1 to 0.1); P = 0.58]. Similarly, no significant change was noted in any secondary outcome measures between the control and intervention periods. Post-hoc analyses limited to high adherers (≥75% attendance; n = 11) did not differ from the primary analysis, indicating no dose-response effect of our intervention.

CONCLUSION:

Our 12-week PRT intervention did not change PWV or any secondary outcomes. Future studies should determine if higher dosages of intradialytic PRT (i.e. longer duration and/or higher intensity) can be applied as a method to improve arterial stiffness to potentially reduce cardiovascular disease and associated mortality this cohort.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diálise Renal / Treinamento Resistido / Análise de Onda de Pulso / Falência Renal Crônica Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diálise Renal / Treinamento Resistido / Análise de Onda de Pulso / Falência Renal Crônica Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article